AI Enabled X-Ray Imaging Solutions Market Size, Share and Trends Analysis, By Component (Hardware, Software and Services), By Deployment Mode (Cloud-Based, On-Premise, Edge Deployment / On-Device AI, and Hybrid), By Technology Type, By Imaging Modality, By Application, By End-Use, and By Region, Forecast 2025-2032

AI Enabled X-Ray Imaging Solutions Market Overview and Key Insights:

The AI Enabled X-Ray Imaging Solutions market size reached USD 1,955.7 Million in 2024 and is expected to register a revenue CAGR of 20.8% during the forecast period. AI solutions for X-rays are built into the imaging system and help detect subtle or complicated patterns in the images, putting crucial cases to the top of the radiologist reading worklist in real time.

Market Drivers:

Increase in prevalence of chronic diseases is a key driver of revenue growth in the AI enabled X-Ray imaging solutions market. According to the Breast Cancer Foundation, in 2025, one out of every eight women in the United States will be diagnosed with breast cancer during her lifetime. In 2025, a projected 316,950 women and 2,800 men will be diagnosed with invasive breast cancer, while another 59,080 new instances of non-invasive (in situ) breast cancer would be detected. There are currently more than 4 million breast cancer survivors in the United States.

The FDA has approved 950 Artificial Intelligence (AI) or machine learning-enabled products as of August 2024. In 2015, the FDA approved six AI medical devices. The trend has been pushed by more connected devices, increased investment in AI and machine learning, and growing awareness with how software is regulated as a medical device. Radiology continues to be the most common application for AI/ML-enabled devices, accounting for 750 of the 950 authorized devices. This supremacy is due to the enormous advantages AI/ML provides in picture processing, pattern recognition, and diagnosis accuracy.

On March 2025, GE HealthCare announced a collaboration with NVIDIA at GTC 2025, expanding the two companies’ current connection to focus on pioneering innovation in autonomous imaging, starting with autonomous X-ray technologies and autonomous ultrasound applications. GE HealthCare intends to develop AI-enabled X-ray and ultrasound equipment using the new NVIDIA Isaac for Healthcare platform, which is based on NVIDIA’s three computers used to create physical AI, including the NVIDIA Omniverse for robotic simulation workflows.

Market Opportunity:

Expansion of mobile and portable X-ray units acts as opportunities for AI Enabled X-ray imaging solutions market. Portable X-ray technology provides substantial benefits to people in remote areas, particularly those who are unable to go to healthcare facilities. Their mobility enables quick deployment in temporary emergency units, mobile clinics, or field hospitals where regular radiological equipment may be limited or unavailable. Many rural hospitals and clinics lack the financial resources or patient volume to justify the purchase of numerous radiology rooms. Portable X-ray systems are a viable alternative, providing these facilities with critical imaging capabilities without the significant expenditures associated with regular systems.

On August 2024, DocGo Inc., a leading supplier of technology-enabled mobile health services, announced the introduction of an innovative mobile x-ray program in collaboration with MinXray. An initiative in New York City provides underprivileged people with timely and accessible chest x-rays and helps identify active Tuberculosis cases. DocGo’s mobile units, equipped with MinXray’s revolutionary ultra-portable, battery-powered x-ray equipment, provide chest x-rays to patients who test positive for tuberculosis through blood testing.

Recent Trends:

Emerging trends include edge AI, multi-modal AI integration, integration with telehealth and remote diagnostics, AI-powered workflow optimization, and cloud-based AI platforms.

Integrating imaging data with genomes and clinical information can result in more precise forecasts and individualized treatment approaches, thereby increasing precision medicine. In January 2025, India introduced the Indian Genomic Data Set and Indian Biological Data Centre (IBDC) portals, making 10,000 full genome samples available to researchers worldwide. This effort seeks to establish a self-sufficient biotech ecosystem by simplifying the integration of genomic data with clinical and imaging data for personalized healthcare solutions.

Furthermore, in January 2025, University Hospitals Cleveland Medical Center (UH) has announced a ground-breaking collaboration with global healthcare Artificial Intelligence (AI) innovator Qure.ai to deploy chest X-ray AI for earlier detection of lung malignancies. The FDA-approved chest X-ray AI solution qXR-LN will serve as a secondary read, compared to radiologists’ readings of patient chest X-rays for any suspected lung nodules. This will also serve as evidence for future AI research.

Restraints & Challenges:

AI implementation entails cybersecurity risks and issues that practices must be aware of and address to ensure a successful and secure deployment. According to the Health Insurance Portability and Accountability Act (HIPPA), in 2023, organizations reported an average of 1.99 healthcare data breaches per day involving 500 or more records, exposing 364,571 healthcare records daily. Although a similar number of breaches occurred in 2024, the number of affected individuals increased significantly. In 2024, attackers compromised or stole the protected health information of 2.7 million people.

Furthermore, AI systems can unintentionally reinforce biases in training data, resulting in discrepancies in healthcare results. For example, if an AI algorithm is primarily trained on data from urban populations, its applicability to rural regions may suffer, resulting in incorrect predictions or diagnoses. Some AI models’ nature may make them unsuitable for clinical use. Healthcare personnel may be hesitant to depend on AI-driven advice in the absence of clear decision-making guidance.

Component Segment Insights and Analysis:

Based on the component, the AI enabled X-ray imaging solutions market is segmented into Hardware, Software, Services.

Software segment contributed the largest market share in 2024. AI in medical imaging is one of the most significant technological advancements in diagnostics and patient care. Imaging technology in healthcare analyzes vast amounts of data faster than ever before, resulting in reduced diagnostic times. These accidents have created new prospects for medical AI software development. AI healthcare solutions can significantly improve the ratio of growing imaging services for healthcare units. Because this method involves assessing images from remote centers, diagnosis is extended to the peripheral centers.

On June 2024, Strategic Radiology, a coalition of independently owned and operated local private radiology practices, and Qure.ai, a global leader in healthcare AI, have announced a collaboration to improve clinical accuracy and operational efficiency by providing easier access to cutting-edge medical imaging AI technology. Strategic radiography, with over 1700 radiologist members, is at the forefront of helping private practice radiography groups across the country through ongoing education programs, improved economics associated with increased scale, and access to cutting-edge technology developments.

Technology Type Segment Insights and Analysis:

Based on the technology type, the AI enabled X-ray imaging solutions market is segmented into Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Computer Vision, and Federated Learning.

Machine Learning (ML) segment contributed the largest market share in 2024. AI, particularly its subset machine learning, is significantly enhancing radiology by boosting picture processing and reducing diagnostic errors. AI algorithms process and interpret data, doing activities that mimic or even outperform human cognitive powers. ML, when exposed to labeled samples, can extract complicated, high-level data from unlabeled datasets. Integrating AI into VR/AR technology has the potential to significantly improve radiological efficiency, diagnosis accuracy, and treatment planning.

To improve the performance of CAD and increase the productivity of radiology services through AI-assisted workflow, the radiology community has improved computer-aided diagnosis (CAD) tools based on machine learning (ML) over the past 20 years. These tools are expected to create an integrated diagnostic service by combining radiology, pathology, and genomics data.

On September 2024, Harrison.ai, a healthcare AI technology startup, has announced the launch of Harrison.rad.1, a radiology-specific vision language model. Harrison.rad.1 is a conversational vision language model for radiology. It may perform a range of operations, such as open-ended X-ray image chat, detection and localization of radiological discoveries, and report generation, as well as longitudinal reasoning based on clinical history and patient context.

Application Segment Insights and Analysis:

Based on the application, the AI enabled X-ray imaging solutions market is segmented into thoracic, musculoskeletal, oncology, breast, dental, and others.

Oncology segment contributed the largest market share in 2024. According to the Lung Cancer Research Foundation, lung cancer is the main cause of cancer deaths worldwide. An estimated 226,650 people will be diagnosed with lung cancer in the United States by 2025. One in every 16 people will be diagnosed with lung cancer at some point in their lives, with one in every 17 women and one in every 16 males. Smoking is the main risk factor for lung cancer, accounting for 80% of lung cancer fatalities. People who have never smoked are responsible for 20% of lung cancer deaths.

On February 2025, DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc., demonstrated next-generation AI-powered radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna. DeepHealth OS powers eepHealth’s solutions, which integrate data across several solutions and enable interoperability with larger healthcare IT ecosystems. Furthermore, to facilitate large-scale AI adoption, DeepHealth has formed strategic alliances with ecosystem industry leaders to allow integrated solutions.

Geographical Outlook:

AI enabled X-ray imaging solutions market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamic. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different region and countries.

North America AI Enabled X-Ray Imaging Solutions Market:

North America is registered to have highest market share in AI enabled X-ray imaging solutions market in 2024. This is mainly driven by increase in prevalence of chronic diseases, rising diagnostic imaging demand. Furthermore, technological Advancements in AI is also augmenting the growth of the market. According to the World Health Organization (WHO), in 2023, a projected 10.8 million individuals worldwide became ill with tuberculosis, including 6.0 million men, 3.6 million women, and 1.3 million children. Tuberculosis is prevalent in all countries and age groups. Tuberculosis is treatable and preventative. MDR-TB remains a public health emergency and a security threat. Only roughly two out of every five persons with drug-resistant tuberculosis received treatment in 2023.

On October 2023, Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund) announced a partnership at the World Health Summit to accelerate the application of artificial intelligence (AI) in tuberculosis (TB) diagnosis. The two businesses will collaborate to accelerate the use of AI in chest X-rays, increasing efficiency and accuracy.  Routine scans can be read faster with AI, allowing more people to be checked for tuberculosis and diagnosing cases that were previously undiagnosed.

Asia Pacific AI Enabled X-Ray Imaging Solutions Market:

Asia Pacific is expected to register the fastest growth rate during the forecasted period, driven by expansion of mobile and portable X-ray units and integration with tele-radiology platforms. Moreover, increase in prevalence of chronic diseases and rising diagnostic imaging demand is also driving the market in the region. Telehealth services are undergoing a significant transformation in the Asia-Pacific (APAC) region, with artificial intelligence playing a critical role.

From automated patient monitoring to real-time diagnostics, AI tackles important healthcare concerns across clinical practices. While AI integration in research is still evolving, the Asia-Pacific region has enormous potential for tailoring manufacturing and commercial AI applications to local requirements. China and India offer massive technical skill pools, while Japan and South Korea host a large user base for AI-enabled solutions. Singapore and Australia maintain robust healthcare data infrastructures and demonstrate excellent AI development skills.

In October 2024, the Mayo Clinic Platform Accelerate has established a strategic partnership with the Japan External Trade Organization (JETRO) to launch a two-phase program to improve U.S. healthcare and business immersion prospects for Japanese health technology businesses. In the first phase, 16 Japanese companies will gain insights from Mayo Clinic Platform_Accelerate’s educational immersion program, which aims to provide firsthand experience in observing how healthcare professionals use or would benefit from artificial intelligence (AI) in their clinical practices.

Europe AI Enabled X-Ray Imaging Solutions Market:

Europe is expected to register the considerable growth rate during the forecasted period driven by rising diagnostic imaging demand, shortage of radiologists and high workload, technological advancements in AI. In February 2025, Unilabs, Europe’s top diagnostic services provider, announced the selection of AI solutions from Oxipit, a pioneering medical imaging AI business, to deploy solutions for chest X-rays across the Unilabs European network. Oxipit’s AI technologies, ChestLink and ChestEye, will be integrated into Unilabs’ radiology workflows to improve chest X-ray reporting through automated triage and second-reading capabilities. The agreement includes the opportunity to employ these technologies across the Unilabs group in Europe, with the initial implementation beginning in Portugal.

Moreover, on April 2024, Bayer and Google Cloud have launched a collaboration to develop artificial intelligence (AI) solutions that will help radiologists and, eventually, better serve patients. As part of the agreement, Bayer will expand its innovation platform to expedite the development and implementation of AI-powered healthcare apps, with a particular emphasis on radiology, by leveraging Google Cloud technology, including its generative AI (gen AI) tools.

Competition Analysis:

The AI enabled X-ray imaging solutions market is characterized by a fragmented structure, with several players competing across various segments and regions. list of major players included in the AI enabled X-ray imaging solutions market report are:

• Siemens Healthineers AG
• GE HealthCare
• oxipit.ai
• Tempus AI
• DeepTek.ai, Inc
• Aidoc Medical Ltd.
• L&T Technology Services Limited
• FUJIFILM Corporation
• CARPL.ai
• DeepHealth
• Philips
• Agfa Radiology Solutions
• Rad AI
• Gleamer Copilot
• Infervision

Strategic Developments in AI Enabled X-Ray Imaging Solutions Market:

• In February 2025, Harrison.ai, a Sydney, Australia-based firm, raised USD 112 million (AUD 179 million) in Series C funding to expand its international footprint in important regions such as the United States, Europe, the Middle East, and Asia. Aware Super, ECP Asset Management, and Horizons Ventures led the investment round, which also included new investors such as the National Reconstruction Fund, Ord Minnett, and Wollemi Capital Group, as well as returning partners Alpha JWC Ventures and Blackbird Ventures.
• In February 2025, SimonMed Imaging and HeartLung Technologies have formed a strategic agreement to provide HeartLung’s AI-enabled automated bone mineral density screening for detecting bone loss (osteopenia and osteoporosis) in CT images. This collaboration marks a significant milestone in both organizations’ quest to make cutting-edge technology available and affordable to patients. This AI solution will assist Americans become aware of their bone loss before it has harmful repercussions, such as a bone fracture.
• In January 2024, Boston Imaging, Samsung’s digital radiography (DR) and ultrasound business’s headquarters in the United States, announced that the company has signed a supply contract with Lunit Inc. The Lunit INSIGHT CXR, an AI-powered chest X-ray analysis solution, and the Lunit Insight CXR Triage, an FDA 510(k)-cleared AI triage solution for critical chest findings, will allow Samsung’s CAD (Computer Aided Detection) AI to assist radiologists in managing the unprecedented volume of patient exams by prioritizing those with suspected abnormalities.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights Of The AI Enabled X-Ray Imaging Solutions Market Report:

The AI Enabled X-Ray Imaging Solutions market report offers a detailed analysis of market size, including historical revenue (in USD Million) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Component Outlook (Revenue, USD Million; 2022-2032)
  • Hardware
  • Software
  • Services

• Deployment Mode Outlook (Revenue, USD Million; 2022-2032)
  • Cloud-Based
  • On-Premise
  • Edge Deployment / On-Device AI
  • Hybrid

• Technology Type Outlook (Revenue, USD Million; 2022-2032)
  • Machine Learning (ML)
  • Deep Learning (DL)
  • Natural Language Processing (NLP)
  • Computer Vision
  • Federated Learning

• Imaging Modality Outlook (Revenue, USD Million; 2022-2032)
  • Digital Radiography (DR)
  • Computed Radiography (CR)
  • Tomosynthesis (3D mammography)
  • Portable & Mobile X-ray
  • Dental X-ray
  • Fluoroscopy & C-arm X-ray systems

• Application Outlook (Revenue, USD Million; 2022-2032)
  • Thoracic
  • Musculoskeletal
  • Oncology
  • Breast
  • Dental
  • Others

• End-Use Outlook (Revenue, USD Million; 2022-2032)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Tele-radiology Service Providers
  • Academic & Research Institutions

• Regional Outlook (Revenue, USD Million; 2022-2032)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Benelux
    • Nordic Countries
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Oceania
    • ASEAN Countries
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Frequently Asked Questions (FAQ) about the AI Enabled X-Ray Imaging Solutions market report